Evidence map›Paper›PMID 32342980›Full record

ArticleAge and ageing2020

Transitions between frailty states in the very old: the influence of socioeconomic status and multi-morbidity in the Newcastle 85+ cohort study.

Nuno Mendonça, Andrew Kingston, Mohammad Yadegarfar, Helen Hanson, Rachel Duncan, Carol Jagger, Louise Robinson

Abstract read
In one paragraph

Article in Age and ageing, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Change in a Claims-Based Frailty Index, Mortality, and Health Care Costs in Medicare Beneficiaries.The journals of gerontology. Series A, Biological sciences and medical sciences · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nuno MendonçaPopulation Health Sciences Institute, Newcastle University, NE2 4AX, UK.
Andrew KingstonPopulation Health Sciences Institute, Newcastle University, NE2 4AX, UK.
Mohammad YadegarfarLeeds Institute of Cardiovascular and Metabolic Medicine, Leeds University, UK.
Helen HansonPopulation Health Sciences Institute, Newcastle University, NE2 4AX, UK.
Rachel DuncanPopulation Health Sciences Institute, Newcastle University, NE2 4AX, UK.
Carol JaggerPopulation Health Sciences Institute, Newcastle University, NE2 4AX, UK.
Louise RobinsonPopulation Health Sciences Institute, Newcastle University, NE2 4AX, UK.

Funding

Biotechnology and Biological Sciences Research CouncilBritish Heart Foundation PG/08/026/24712Medical Research Council G0500997Medical Research Council G0601333Medical Research Council MR/J50001X/1
6 · The paper itself

Abstract

backgroundUsing Newcastle 85+ Study data, we investigated transitions between frailty states from age 85 to 90 years and whether multi-morbidities and socioeconomic status (SES) modify transitions.

methodsThe Newcastle 85+ Study is a prospective, longitudinal cohort study of all people born in 1921 in Newcastle and North Tyneside. Data included: a multidimensional health assessment; general practice record review (GPRR) and date of death. Using the Fried phenotype (participants defined as robust, pre-frail or frail), frailty was measured at baseline, 18, 36 and 60 months.

resultsFrailty scores were available for 82% (696/845) of participants at baseline. The prevalence of frailty was higher in women (29.7%, 123/414) than men (17.7%, 50/282) at baseline and all subsequent time points. Of those robust at baseline, 44.6% (50/112) remained robust at 18 months and 28% (14/50) at age 90. Most (52%) remained in the same state across consecutive interviews; only 6% of the transitions were recovery (from pre-frail to robust or frail to pre-frail), and none were from frail to robust. Four or more diseases inferred a greater likelihood of progression from robust to pre-frail even after adjustment for SES. SES did not influence the likelihood of moving from one frailty state to another.

conclusionsAlmost half the time between age 85 and 90, on average, was spent in a pre-frail state; multi-morbidity increased the chance of progression from robust and to frail; greater clinical intervention at the onset of a first chronic illness, to prevent transition to multi-morbidity, should be encouraged.

Indexed as

FrailtyAgedAged, 80 and overCohort StudiesFemaleFrail ElderlyHumansLongitudinal StudiesMaleMultimorbidityPrevalenceProspective StudiesSocial Classaged 80 and overdeprivationfrailtymulti-morbidityolder people, education

Identifiers

PMID32342980
PMCPMC7583524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.